iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.
暂无分享,去创建一个
Eric E Schadt | Kevin Eggan | Daniel Paull | Hongyan Zhou | Lorraine Clark | Lee Rubin | Chris M Woodard | Matthew Zimmer | Scott A Noggle | E. Schadt | K. Eggan | L. Rubin | D. Sulzer | S. Lipnick | E. Mosharov | L. Clark | Stephen Chang | S. Sardi | S. Kuo | S. Noggle | Mathew Brock | Mahendra S. Rao | David Sulzer | M. Zimmer | Daniel Paull | M. Nestor | Mathew Brock | Brian A Campos | Sheng-Han Kuo | Melissa J Nirenberg | Michael W Nestor | Eugene V Mosharov | Sergio Pablo Sardi | Scott Lipnick | Mahendra Rao | Stephen Chang | Aiqun Li | Aiqun Li | Michael W. Nestor | Hongyan Zhou | M. Nirenberg
[1] Nicholas Eriksson,et al. Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.
[2] Patrick A. Lewis,et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.
[3] Sunhong Kim,et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.
[4] Werner Poewe,et al. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. , 2009, The New England journal of medicine.
[5] P. Pollak,et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers , 2012, Neurology.
[6] S. Tabrizi,et al. Correction: PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons , 2008, PLoS ONE.
[7] Zhen Yan,et al. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells , 2012, Nature Communications.
[8] Blake Byers,et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.
[9] Ying Sun,et al. Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.
[10] J. Hardy,et al. Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains , 2012, Annals of neurology.
[11] J W Langston,et al. Parkinson disease in twins: an etiologic study. , 1999, JAMA.
[12] A. Schapira,et al. Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease , 2013, Cell metabolism.
[13] O. Isacson,et al. Markers and Methods for Cell Sorting of Human Embryonic Stem Cell‐Derived Neural Cell Populations , 2007, Stem cells.
[14] Ronald Melki,et al. Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport , 2012, Annals of neurology.
[15] M. Nalls,et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.
[16] Stormy J. Chamberlain,et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes , 2010, Proceedings of the National Academy of Sciences.
[17] D. Surmeier,et al. Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.
[18] Ying Sun,et al. Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing , 2011, Annals of neurology.
[19] E. Sidransky,et al. Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders , 2010, Acta Neuropathologica.
[20] K. Marder,et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. , 2010, Archives of neurology.
[21] J. Rothstein,et al. Epigenetic regulation of neuron‐dependent induction of astroglial synaptic protein GLT1 , 2009, Glia.
[22] M. Memo,et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.
[23] F. Gage,et al. Cell-Surface Marker Signatures for the Isolation of Neural Stem Cells, Glia and Neurons Derived from Human Pluripotent Stem Cells , 2011, PloS one.
[24] John R. Yates,et al. Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription , 2013, Cell.
[25] Christine Klein,et al. Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease , 2012, Science Translational Medicine.
[26] H. Okano,et al. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.
[27] Torsten Kluba,et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. , 2013, Cell stem cell.
[28] G. Wenning,et al. Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons. , 2013, Stem cells and development.
[29] A. Björklund,et al. Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons , 2012, Proceedings of the National Academy of Sciences.
[30] S. Lipton,et al. Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription , 2013, Cell.
[31] Akira Wada,et al. DNA Methylation of the Monoamine Oxidases A and B Genes in Postmortem Brains of Subjects with Schizophrenia , 2012 .
[32] M. Tomishima,et al. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. , 2012, The Journal of clinical investigation.
[33] Chuong B. Do,et al. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.
[34] N. Pedersen,et al. Heritability of Parkinson disease in Swedish twins: a longitudinal study , 2011, Neurobiology of Aging.
[35] R. Sidman,et al. CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy , 2011, Proceedings of the National Academy of Sciences.